🔎 Trials Near Me

Home › Impeksyon sa Respiratory Tract › Texas

Pag-aaral pangklinika para sa Impeksyon sa Respiratory Tract sa Texas

5 pag-aaral para sa Impeksyon sa Respiratory Tract ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Amarillo
  • Research Site, Dallas
  • Research Site, El Paso
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05624450

A Study of COVID-19 Vaccine(s) in Children and Adults

  • Cedar Health Research, Dallas
  • Cedar Health Research, Euless
  • DM Clinical Research-Cyfair, Houston
  • at 1 pa
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 5 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07798648

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Zenos Clinical Research, Dallas
  • Baylor Scott & White Health - Center for Advanced Heart and Lung Disease, Dallas
  • Baylor Scott & White Research Institute - Clinical Trials Office, Dallas
  • at 8 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07013474

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Zenos Clinical Research, Dallas
  • Southwest Family Medicine Associates, Dallas
  • Southwest Mind and Body Care, Dallas
  • at 9 pa
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06679140

An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.

  • The University of Texas Health Science Center at Houston, Houston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT06070688

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.